EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Catheter‐Directed Ionic Liquid Embolic Agent for Rapid Portal Vein Embolization, Segmentectomy, and Bile Duct Ablation

Enes Cevik, Hassan Albadawi, Zefu Zhang, Yusuf Demirlenk, Dila Atar, Chris Keum, Jinjoo Kim, Erin Graf, Seyda Gunduz, Suliman Rehman, Rahmi Oklu iD

Advanced Materials · 2024

DOI: 10.1002/adma.202402570 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, 2024. Verfasst von Enes Cevik und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Vascular & Interventional Radiology, Laboratory for Patient Inspired Engineering, Mayo Clinic, 13400 East Shea Blvd, Scottsdale, AZ, 8525…. Hauptthemen laut MEDLINE: Portal Vein, Embolization, Therapeutic, Ionic Liquids. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS, NCI NIH HHS, NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Embolic materials currently in use for portal vein embolization (PVE) do not treat the tumor, which poses a risk for tumor progression during the interval between PVE and surgical resection. Here, is developed an ionic‐liquid‐based embolic material (LEAD) for portal vein embolization, liver ablation, and drug delivery. LEAD is optimized and characterized for diffusivity, X‐ray visibility, and cytotoxicity. In the porcine renal embolization model, LEAD delivered from the main renal artery reached vasculature down to 10 microns with uniform tissue ablation and delivery of small and large therapeutics. In non‐survival and survival porcine experiments, successful PVE is achieved in minutes, leading to the expected chemical segmentectomy, and delivery of a large protein drug (i.e., Nivolumab) with LEAD. In cholangiocarcinoma mouse tumor models and in ex vivo human tumors, LEAD consistently achieved an effective ablation and wide drug distribution. Furthermore, various strains of drug‐resistant patient‐derived bacteria showed significant susceptibility to LEAD, suggesting that LEAD may also prevent infectious complications resulting from tissue ablation. With its capabilities to embolize, ablate, and deliver therapeutics, ease of use, and a high safety profile demonstrated in animal studies, LEAD offers a potential alternative to tumor ablation with or without PVE for FLR growth.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Portal VeinEmbolization, TherapeuticIonic LiquidsAnimalsMiceHumansSwineCell Line, TumorCathetersBile DuctsBile Duct Neoplasms

Stichwörter der Autor:innen

ablationdrug deliveryembolizationimmunotherapyportal vein

Substanzen

Ionic Liquids

Autor:innen und Institutionen

  • Division of Vascular & Interventional Radiology, Laboratory for Patient Inspired Engineering, Mayo Clinic, 13400 East Shea Blvd, Scottsdale, AZ, 85259, USA.
  • Department of Laboratory Medicine and Pathology, Mayo Clinic, 5777 E Mayo Blvd, Phoenix, AZ, 85054, USA.
  • Department of Medical Oncology, Istinye University Bahcesehir Liv Hospital, Istanbul, 34517, Turkey.

ORCID-Profile: Rahmi Oklu

Förderung

  • NHLBI NIH HHS
  • NCI NIH HHS
  • NIDDK NIH HHS
  • Mayo Clinic
  • National Cancer Institute
  • National Heart, Lung, and Blood Institute
  • National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Cevik, E., Albadawi, H., Zhang, Z., Demirlenk, Y., Atar, D., Keum, C., Kim, J., Graf, E., Gunduz, S., Rehman, S., & Oklu, R. (2024). Catheter‐Directed Ionic Liquid Embolic Agent for Rapid Portal Vein Embolization, Segmentectomy, and Bile Duct Ablation. Advanced Materials. https://doi.org/10.1002/adma.202402570

Vancouver

Cevik E, Albadawi H, Zhang Z, Demirlenk Y, Atar D, Keum C, et al. Catheter‐Directed Ionic Liquid Embolic Agent for Rapid Portal Vein Embolization, Segmentectomy, and Bile Duct Ablation. Advanced Materials. 2024. doi:10.1002/adma.202402570

BibTeX
@article{Cevik2024,
  author = {Cevik, Enes and Albadawi, Hassan and Zhang, Zefu and Demirlenk, Yusuf and Atar, Dila and Keum, Chris and Kim, Jinjoo and Graf, Erin and Gunduz, Seyda and Rehman, Suliman and Oklu, Rahmi},
  title = {Catheter‐Directed Ionic Liquid Embolic Agent for Rapid Portal Vein Embolization, Segmentectomy, and Bile Duct Ablation},
  journal = {Advanced Materials},
  year = {2024},
  doi = {10.1002/adma.202402570}
}
Kostenlos starten →